Results 211 to 220 of about 13,000,271 (286)

Long‐term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9

open access: yesJournal of Controlled Release, 2019
C. Stephens   +5 more
semanticscholar   +1 more source

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options. [PDF]

open access: yesRes Pract Thromb Haemost
Zülfikar B   +41 more
europepmc   +1 more source

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

open access: green, 2004
Valder R. Arruda   +9 more
openalex   +2 more sources

Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B [PDF]

open access: green, 2009
Nicola Brunetti‐Pierri   +7 more
openalex   +1 more source

Liver-directed lentiviral gene therapy in a dog model of hemophilia B

open access: yesScience Translational Medicine, 2015
Alessio Cantore   +21 more
semanticscholar   +1 more source

603. Correction of Hemophilia B Phenotype by Novel Method of Regional Intravenous Delivery of AAV Vector to Skeletal Muscle of Hemophilia B Dogs

open access: hybrid, 2005
Valder R. Arruda   +9 more
openalex   +1 more source

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial

open access: yesJournal of Thrombosis and Haemostasis, 2016
M. Carcao   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy